Puzo Michael J acquired a new stake in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 17,353 shares of the company’s stock, valued at approximately $2,230,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Gables Capital Management Inc. acquired a new stake in shares of Merck KGaA during the 2nd quarter valued at $2,095,000. Diversify Advisory Services LLC purchased a new position in shares of Merck KGaA during the 2nd quarter valued at $3,810,000. Danske Bank A S acquired a new position in shares of Merck KGaA in the second quarter worth $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new stake in shares of Merck KGaA during the second quarter worth $25,541,000. Finally, BOK Financial Private Wealth Inc. purchased a new stake in shares of Merck KGaA during the second quarter worth $523,000. Hedge funds and other institutional investors own 0.10% of the company’s stock.
Merck KGaA Price Performance
MKGAF opened at $167.38 on Thursday. The stock has a fifty day moving average price of $162.50 and a 200 day moving average price of $148.28. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The stock has a market cap of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
